HSA — authorised 21 December 2012
- Marketing authorisation holder: AEGERION
- Status: likely_approved
HSA authorised Juxtapid on 21 December 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 21 December 2012.
AEGERION holds the Singaporean marketing authorisation.